~~<i id='FDA5EE0A94'><strike id='FDA5EE0A94'><tt id='FDA5EE0A94'><pre id='FDA5EE0A94'></pre></tt></strike></i>~~

Home» explore» focus

focus

author：Wikipedia 2025-10-01 04:35:21 Page View：5189

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： WuXi Biologics beefs up its lobbying operation
Next article： Novavax promises a turnaround & Lilly roils the obesity market

leisure time

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

First transplant of an entire human eye performed

EduardoRodriguez,NYULangoneHealth'schairofplasticsurgery,examinesAaronJamesinNewYorkonOct.23.InMay,J

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

ReporterNicholasFlorkoholdsthejugof"petmilk"fromMarylandthathepickedupinWashington,D.C.NicholasFlork

WSS

focus

focus

knowledge

leisure time

Raw milk easy to obtain despite bird flu warning, FDA interstate ban